Home/ Supplements/ Vitamin K/ Vitamin K12

Vitamin K12

product on market Capsule CHK Nutrition Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

MenaquinGold Vitamin K2 supports calcium homeostasis by directing minerals into the bone matrix and away from arterial walls. There is moderate research evidence regarding its role in bone density and cardiovascular health. The ingredient profile maintains a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Vitamin K12
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mcg (38% DV)
Within RDA (0.4× RDA) 275 studies (A:9, B:175)

Other Ingredients

Vegetarian Capsule Cellulose Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, adults take one (1) vegetarian capsule daily at mealtime, or as directed by a health care professional.

Warnings & Precautions

Keep out of reach of children.

Formulation Notes

Contains no salt, dairy, wheat, gluten, soy, preservatives, artificial colors or flavors.

Natural color variations may occur in this product.

All natural source Supports bone building and healthy arteries

Vitamin K2 (menaquinone) is an all-natural form of Vitamin K that is much more biologically active than the more common form, Vitamin K1 (phylloquinone). Vitamin K2 increases the body's formation of osteocalcin, which helps calcium is critical to the growth and strength of bones. Vitamin K2 also increases the formation of protein (matrix GLA-protein) which regulates the amount of calcium present in arterial walls. This helps maintain the elasticity and overall health of arteries.

Quality and potency guaranteed

Additional Information

Store in a cool, dry place and away from direct light.

New day. Fresh start. Better health.

Metadata

Product Details

UPC / SKU7 87500 02122 2
DSLD Entry Date2020-06-24
Product TypeVitamin
FormCapsule
DSLD ID228639
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.